Search
Research
Developing a novel therapeutic pipeline for antibiotic resistant bacterial lung infection in children: investigating and assessing the potential phage therapyAntimicrobial resistance is a global health crisis, which has accelerated due to the overuse of antibiotics.
Research
Mindful Self-Compassion for LGBTQIA+ youthThe aim of this project is to see if a mindful self-compassion group training program delivered via videoconference is helpful for improving mental health and wellbeing in LGBTQIA+ young people.
Research
DEFEND CF: Biomarkers to define the treatment end-point for pulmonary exacerbations in cystic fibrosisSensitive and reliable tests are required to monitor lung disease severity in cystic fibrosis.
Research
Aboriginal and Torres Strait Islander Partnerships to Prevent Permanent Lung Disease (APPLE Study)In partnership with Aboriginal health services, Government agencies and communities, we will develop and implement evidence-based strategies to improve the detection and management of chronic wet cough in Aboriginal and Torres Strait Islander children.
Research
Prevalence of chronic wet cough, protracted bacterial bronchitis (PBB) and middle ear disease in the KimberleyThis project aims to determine the prevalence of chronic wet cough, PBB and middle ear disease in Aboriginal children in Aboriginal communities in the Kimberley.
Research
Maximising fathers’ roles in preventing adolescent alcohol-related harm. (Fathers and Adolescent Alcohol Use Project)This project will explore fathers’ attitudes and behaviours regarding the alcohol-related parenting of 10-17-year-old children.
Research
Review of Inclusive Preschool ProgramYasmin Harman-Smith BA, BHlthSc(Hons), PhD Head, Early Years Systems Evidence; Head, Tenders Support Unit Yasmin.harman-smith@thekids.org.au Head,
Research
Future Child HealthThe greatest threat to children’s health in the future is environmental change, including climate change. The Future Child Health project aims to quantify how current and future environmental changes affect child health.
Research
COVALIA (COVid vaccine trial for austrALIA): A phase I, double-blind, dose-ranging, randomised, placebo-controlled trial to study the safety and immunogenicity of a DNA-based vaccine against COVID-19 (COVIGEN) in healthy participants aged 18 to 75 years oPeter Richmond MBBS MRCP(UK) FRACP Head, Vaccine Trials Group Head, Vaccine Trials Group Professor Peter Richmond is Head of the Vaccine Trials Group
Research
Considerations for Causal Inference StudiesRachel Foong BSc (hons), PhD, MBiostat Honorary Research Associate 08 6319 1626 Rachel.Foong@thekids.org.au Senior Research Fellow Dr Foong is an